American Association for Laboratory Animal Science

The Inner Circle Acknowledges, Sally A. Campbell as a Pinnacle Life Member for her contributions to the field of Air Pollution

Retrieved on: 
Friday, October 20, 2023

TRAVELERS REST, S.C., Oct. 20, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Sally A. Campbell is acknowledged as a Pinnacle Life Member for her contributions to the field of Air Pollution.

Key Points: 
  • TRAVELERS REST, S.C., Oct. 20, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Sally A. Campbell is acknowledged as a Pinnacle Life Member for her contributions to the field of Air Pollution.
  • Dr. Campbell attended Wellesley College in 1964 where she earned a Bachelor's degree in Physical Chemistry.
  • The doctor entered the field in 1979 as the technical director of atmospheric services with the Martin Marietta Corporation, now Lockheed Martin Corporation, and Martin Marietta Materials.
  • A recognized leader, Dr. Campbell is president of S.A. Campbell and provides air quality analysis for Industrial sites throughout the United States helping them solve problems and acquire air mission permits.

The Inner Circle Acknowledges, Sally A. Campbell as a Pinnacle Platinum Member for her contributions to the field of Air Pollution

Retrieved on: 
Wednesday, July 5, 2023

TRAVELERS REST, S.C., July 5, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Sally A. Campbell is acknowledged as a Pinnacle Platinum Member for her contributions to the field of Air Pollution.

Key Points: 
  • TRAVELERS REST, S.C., July 5, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Sally A. Campbell is acknowledged as a Pinnacle Platinum Member for her contributions to the field of Air Pollution.
  • Dr. Campbell pursued higher education at Wellesley College in 1964 where she earned a Bachelor's degree in Physical Chemistry.
  • Recognized for her prestigious education and experience, the doctor established S.A. Campbell Assoc., an environmental consulting firm, in 1986.
  • As president of S.A. Campbell, Dr. Campbell provides air quality analysis for Industrial sites throughout the United States and helps them solve problems and acquire air mission permits.

Nu Skin Chief Scientific Officer Dr. Joseph Y. Chang Receives Award for Outstanding Contributions in Personalized Nutrition

Retrieved on: 
Monday, November 7, 2022

Presented by the university's Department of Nutrition, this award is given for extraordinary achievements and contributions to nutritional science.

Key Points: 
  • Presented by the university's Department of Nutrition, this award is given for extraordinary achievements and contributions to nutritional science.
  • He has 35 years of experience in the pharmaceutical and dietary supplement industries and was appointed chief scientific officer and executive vice president of product development at Nu Skin in 2006.
  • Before the acquisition of Pharmanex by Nu Skin Enterprises in 1998, Dr. Chang served as the vice president of clinical studies and pharmacology at Pharmanex.
  • Prior to Pharmanex, Dr. Chang served as president and chief scientific officer of Osteoarthritis Sciences, Inc., as well as Binary Therapeutics, Inc.

NOSTER launches Metabolome Analysis Service of metabolites produced by gut microbiota and announces the recipients of the 2022 NOSTER & Science Microbiome Prize

Retrieved on: 
Monday, July 25, 2022

Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.

Key Points: 
  • Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.
  • Based on these findings Noster has built a comprehensive library of original lipid metabolites produced by gut microbiota.
  • Noster makes full use of this technology to provide state of the art 'Metabolome Analysis Service' for exploring the properties of the still unexplored world of gut microbial metabolites.
  • In addition to 'Metabolome Analysis Service', we also provide an 'Gut Microbiota Analysis Service', which can be used in combination to clarify the correlation between gut microbiota and metabolites.

NOSTER launches Metabolome Analysis Service of metabolites produced by gut microbiota and announces the recipients of the 2022 NOSTER & Science Microbiome Prize

Retrieved on: 
Monday, July 25, 2022

Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.

Key Points: 
  • Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.
  • Based on these findings Noster has built a comprehensive library of original lipid metabolites produced by gut microbiota.
  • Noster makes full use of this technology to provide state of the art 'Metabolome Analysis Service' for exploring the properties of the still unexplored world of gut microbial metabolites.
  • In addition to 'Metabolome Analysis Service', we also provide an 'Gut Microbiota Analysis Service', which can be used in combination to clarify the correlation between gut microbiota and metabolites.

NOSTER launches Metabolome Analysis Service of metabolites produced by gut microbiota and announces the recipients of the 2022 NOSTER & Science Microbiome Prize

Retrieved on: 
Monday, July 25, 2022

Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.

Key Points: 
  • Noster also announced the recipients of the 2022 'NOSTER & Science Microbiome Prize'established by Noster Inc with the American Association for the Advancement of Science (AAAS) publisher of the journal Science.
  • Based on these findings Noster has built a comprehensive library of original lipid metabolites produced by gut microbiota.
  • Noster makes full use of this technology to provide state of the art 'Metabolome Analysis Service' for exploring the properties of the still unexplored world of gut microbial metabolites.
  • In addition to 'Metabolome Analysis Service', we also provide an 'Gut Microbiota Analysis Service', which can be used in combination to clarify the correlation between gut microbiota and metabolites.

Yale’s Department of Psychiatry Chair to Join Clearmind Medicine

Retrieved on: 
Tuesday, June 21, 2022

VANCOUVER, June 21, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (CSE: CMND, OTC Pink: CMNDF, FSE: CWY0) (“Clearmind” or the "Company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced the appointment to its Scientific Advisory Board of John Krystal, Chair of the Psychiatry Department at Yale University’s School of Medicine.

Key Points: 
  • He is best known for leading the discovery of the rapid antidepressant effects of ketamine.
  • Dr. Krystal is a Professor of Translational Research; Psychiatry, Neuroscience, and Psychology; he chairs the Department of Psychiatry at Yale University; and he is Chief of Psychiatry and Behavioral Health at Yale-New Haven Hospital.
  • He is a member of the U.S. National Academy of Medicine and a Fellow of the American Association for the Advancement of Science.
  • Clearmind has established a research collaboration with the Hebrew University of Jerusalem and Bar Ilan University.

SIUE Research on "Clumsy" Pumpkin Toadlets Gains International Attention

Retrieved on: 
Tuesday, June 21, 2022

EDWARDSVILLE, Ill., June 21, 2022 /PRNewswire-PRWeb/ -- A small frog is making big headlines thanks to the intriguing findings of researchers, led by Southern Illinois University Edwardsville's Richard Essner, PhD.

Key Points: 
  • Now, brightly colored Pumpkin Toadlets and the researchers' findings are taking Twitter by storm.
  • Additionally, Science Advances' metric measuring attention on research places the scholarship among the top 5% ever, with related headlines spanning more than nine countries.
  • "We discovered that this group of miniaturized frogs from Brazil, known as Pumpkin Toadlets, are unable to control their landings," Essner said.
  • Pumpkin Toadlets and other miniaturized frogs have the smallest semicircular canals known among adult vertebrates.

Disney Assists with Successful Rehabilitation and Release of Manatee

Retrieved on: 
Friday, March 4, 2022

She was just 28 pounds at the time, making her the smallest manatee ever rescued.

Key Points: 
  • She was just 28 pounds at the time, making her the smallest manatee ever rescued.
  • After a successful initial rehab, Plantaina was released back into the wild (Feb. 2021).
  • Through collaboration with other rehabilitation facilities over the years as part of the Manatee Rescue & Rehabilitation Partnership (MRP) Disney animal care experts provide ill and injured manatees with the stable, controlled environment they need to make a recoveryand prepare for release.
  • Plantaina is one of six manatees to complete rehabilitation at Walt Disney World Resort over the last year.

Numinus to Participate in AAAS 2022 Annual Meeting on February 17-20, 2022

Retrieved on: 
Thursday, February 10, 2022

Dr. Christie, Dr. Barrett and Ms. Patterson will also convene for Media Availability on Sunday, February 20, 2022, at 9:00 a.m.

Key Points: 
  • Dr. Christie, Dr. Barrett and Ms. Patterson will also convene for Media Availability on Sunday, February 20, 2022, at 9:00 a.m.
  • For general information about the event, please visit meetings.aaas.org or contact [email protected] ; for media information, please visit https://meetings.aaas.org/wp-content/uploads/AM22_MA-grids_final.pdf .
  • Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies.
  • At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.